CN Patent

CN106146446B — 达格列净半水合物及其晶型、其制备方法及药物组合物

Assigned to Hangzhou Ling Ye Pharmaceutical Technology Co Ltd · Expires 2019-11-08 · 7y expired

What this patent protects

本发明涉及达格列净半水合物及其晶型C，与现有技术相比，所述达格列净半水合物及其晶型C在水或含水体系中的稳定性高，更适合湿法制粒工艺或制成混悬剂。本发明还涉及所述达格列净半水合物晶型C的制备方法。

USPTO Abstract

本发明涉及达格列净半水合物及其晶型C，与现有技术相比，所述达格列净半水合物及其晶型C在水或含水体系中的稳定性高，更适合湿法制粒工艺或制成混悬剂。本发明还涉及所述达格列净半水合物晶型C的制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN106146446B
Jurisdiction
CN
Classification
—
Expires
2019-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Ling Ye Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.